Learning outcomes
By the end of this lesson you should be able to: classify fungal disease as superficial, subcutaneous and systemic, and identify which are opportunistic; describe the three dermatophyte genera and how tinea infections are named and confirmed; describe Candida species, the germ-tube and chlamydospore tests, and the difference between mucosal and invasive candidiasis; describe Cryptococcus, the India ink preparation and the latex agglutination test, and the treatment of meningitis; describe Aspergillus and mucormycosis and the morphological features that distinguish them; describe the dimorphic systemic fungi; and name the antifungal classes with the mechanism and principal toxicity of each.
Prerequisites
Module 2 — innate immunity, for the neutrophil as the principal defence against filamentous fungi; module 3 — general virology, for the contrast between obligate intracellular and free-living eukaryotes.
The big idea
Fungal disease is a story of two kinds of organism. The dermatophytes and the subcutaneous fungi infect an intact host without needing any defect; Candida and Aspergillus and Cryptococcus are opportunists, and their serious disease is almost always a disease of impaired immunity — neutropenia, corticosteroids, transplant immunosuppression, HIV, or an in-dwelling line. That is the single organising fact of this subject: an otherwise healthy person may be troubled by a ringworm, but a neutropenic patient dies of an Aspergillus.
The therapeutic consequence follows the taxonomy. Because fungi are eukaryotes, the target space is narrower than for bacteria, and antifungal drug choice must exploit the two differences: the ergosterol-rich membrane (amphotericin B and the azoles) and the chitinous wall (echinocandins). The price paid for being a eukaryote is toxicity in parallel — amphotericin B is nephrotoxic precisely because it binds the cholesterol of human cells as well as fungal sterols.
Superficial and cutaneous mycoses
Dermatophytoses are infections of keratinised tissue — skin, hair and nails — by three genera of mould that digest keratin and grow only on dead tissue. They are named by the site, which is why the same organism produces tinea capitis on the scalp, tinea corporis on the trunk, tinea pedis (athlete's foot) on the foot, tinea cruris in the groin, tinea unguium in the nails, and a kerion when the inflammation is intense.
| Genus | Species | Morphology | Clinical signature | Treatment |
|---|---|---|---|---|
| Trichophyton | T. rubrum, T. tonsurans, T. mentagrophytes | Microconidia arranged along the hypha, with spiral hyphae; occasional macroconidia of a cigar shape | Tinea pedis, onychomycosis and tinea corporis — the most common dermatophyte worldwide | Topical terbinafine or clotrimazole for skin; oral terbinafine for hair and nail |
| Microsporum | M. canis (from cats and dogs), M. audouinii | Large spindle-shaped macroconidia with more than six cells | Tinea capitis in children, with a characteristic green fluorescence under Wood's lamp for some species | Oral griseofulvin, because topical agents cannot reach the hair shaft |
| Epidermophyton | E. floccosum | Smooth club-shaped macroconidia, no microconidia | Tinea cruris in the groin and tinea pedis | Topical terbinafine |
NoteThe KOH preparation is the point-of-care test for dermatophytosis: scrapings of skin or nail are dissolved in potassium hydroxide, and the resistant refractile branching septate hyphae remain visible under the microscope. Culture on Sabouraud dextrose agar confirms the species and allows susceptibility testing where needed.
| Other superficial fungi | Disease | Identifying feature |
|---|---|---|
| Malassezia furfur | Pityriasis versicolor — hypo- or hyper-pigmented scaly patches on the chest | A lipophilic yeast with spaghetti-and-meatballs appearance on KOH; needs lipid supplementation in culture |
| Piedraia hortae | Black piedra — hard nodules on hair shafts | Black nodules containing asci, mostly in the humid tropics |
| Trichosporon beigelii | White piedra and invasive trichosporonosis in immunocompromised patients | White nodules, and an emerging pathogen now resistant to echinocandins |
Candida: yeast, pseudohyphae and disease
| Presentation | Setting | Diagnosis | Treatment |
|---|---|---|---|
| Oral thrush | Infancy, inhaled corticosteroids, HIV, dentures, antibiotic use | Creamy plaques removable to leave an erythematous base; microscopy for pseudohyphae | Topical nystatin or oral fluconazole |
| Vulvovaginal candidiasis | Pregnancy, diabetes, broad-spectrum antibiotics, immunosuppression | Curd-like discharge with an acidic pH and hyphae on microscopy | Topical imidazole or single-dose oral fluconazole |
| Intertrigo and napkin dermatitis | Warm moist folds of an infant or an obese adult | Beefy red erythema with satellite lesions | Keep dry, topical nystatin |
| Chronic mucocutaneous candidiasis | A T-cell defect with recurrent mucosal and cutaneous disease | Hyphae on repeated microscopy, and an underlying immune defect to define | Long-term azole therapy |
| Oesophageal candidiasis | AIDS with a low CD4 count | Odynophagia and plaques seen on endoscopy | Fluconazole |
| Invasive candidiasis and candidaemia | Intensive care, total parenteral nutrition, central lines, abdominal surgery, neutropenia | Blood cultures and the beta-D-glucan test; the mortality is high despite therapy | Echinocandin first-line, then fluconazole once the isolate is tested |
| Ocular and renal candidiasis | Dissemination from a line infection | Funduscopy for white chorioretinal plaques | Prolonged systemic therapy plus device removal |
NoteThe germ-tube test is the fastest way to identify Candida albicans: serum is incubated at 37°C for two to three hours, and C. albicans alone of the common species produces a rudimentary hypha — a germ tube — from the budding cell. The chlamydospore test on cornmeal agar confirms it. Candida glabrata, Candida krusei, Candida tropicalis and Candida parapsilosis are identified by their assimilation profiles, and the species changes the treatment because C. glabrata is less fluconazole-susceptible and C. krusei is intrinsically resistant.
Cryptococcus neoformans
Cryptococcus neoformans is an encapsulated yeast whose natural habitat is soil contaminated with pigeon droppings, and whose infection begins in the lungs after the inhalation of desiccated yeast cells. In a person with intact T-cell immunity it stays a pulmonary infection; in a person with advanced HIV it haematogenously seeds the central nervous system and produces a subacute meningitis with headache, fever and, later, cranial nerve deficits.
| Diagnostic method | What is seen | Use |
|---|---|---|
| India ink preparation | The polysaccharide capsule appears as a clear halo around the budding yeast against the black background | The classical rapid CSF test, though sensitivity is modest and antigen detection is preferred |
| Latex agglutination / lateral flow | Cryptococcal antigen detected in CSF and serum | The most sensitive and specific test, quantifying the antigen titre for follow-up |
| Culture on bird-seed agar (niger seed) | Brown-pigmented colonies | Confirmation and speciation |
| Histology | Encapsated budding yeasts on mucicarmine stain | Tissue diagnosis and the assay of pathogen burden |
Watch outTreatment of cryptococcal meningitis is induction with amphotericin B plus flucytosine, followed by a prolonged consolidation course of fluconazole — and intracranial pressure must be managed at the same time, because raised pressure is a major cause of death in this disease. Flucytosine is a nucleotide analogue with marrow toxicity, so full blood counts must be monitored; this is the same drug class antagonism that makes amphotericin now frequently reformulated as a lipid formulation to spare the kidney.
Aspergillus and the moulds that kill the neutropenic patient
| Feature | Aspergillus fumigatus | Mucorales (Rhizopus, Mucor, Rhizomucor) |
|---|---|---|
| Hyphal morphology | Septate hyphae that branch dichotomously at an acute angle of about 45 degrees | Broad, ribbon-like aseptate hyphae that branch at right angles |
| Histology on silver stain | Narrow uniform septate filaments | Wide twisted ribbons without septa |
| Classical disease | Allergic bronchopulmonary aspergillosis, aspergilloma in an old cavity, invasive aspergillosis in neutropenia or transplant | Rhinocerebral zygomycosis in diabetic ketoacidosis, and necrotising cutaneous infection in burns |
| Diagnosis | Galactomannan enzyme immunoassay on serum or bronchoalveolar lavage, and PCR; culture | Culture is often sterile because the organism is fragile; diagnosis rests on histology of a biopsy |
| Treatment | Voriconazole first-line (or isavuconazole); surgical resection for an aspergilloma and debridement in invasive disease | Prompt surgical debridement plus high-dose lipid amphotericin B, and reversal of ketoacidosis |
| Key fact | Aflatoxin B1 produced by A. flavus is a potent hepatocellular carcinogen and a cause of food contamination | Angioinvasion causes tissue infarction, which is why the disease runs a necrotising course |
Watch outThe morphology decides the drug and the prognosis, and it is read from a biopsy rather than a culture. In a patient with neutropenia and a dense pulmonary opacity, narrow septate 45-degree hyphae means invasive aspergillosis and voriconazole, whereas broad aseptate right-angled hyphae means mucormycosis and a request for immediate surgical debridement plus amphotericin B. Mucor is intrinsically resistant to voriconazole, so the wrong morphological read costs the patient several days and their life.
Dimorphic systemic fungi
| Organism | Geography | Disease | Diagnosis and treatment |
|---|---|---|---|
| Histoplasma capsulatum | Ohio and Mississippi valleys; the soil contaminated by bat and bird droppings | Histoplasmosis: a self-limiting febrile illness after exposure, then disseminated disease with hepatosplenomegaly and pancytopenia in the immunosuppressed | Small yeast cells within macrophages on bone marrow; antigen detection; itraconazole for chronic and disseminated disease, amphotericin B for severe |
| Blastomyces dermatitidis | Southeastern United States and Ohio valley | Blastomycosis: pulmonary disease with skin and bone lesions, and verrucous or ulcerated skin lesions | Broad-based budding yeasts on histology; itraconazole, amphotericin B for severe disease |
| Coccidioides immitis | Southwestern United States and Latin America | Coccidioidomycosis: valley fever, with arthralgia, erythema nodosum and pulmonary cavities | Large spherules with endospores on histology; itraconazole for chronic cavitary disease |
| Paracoccidioides brasiliensis | Latin America | Paracoccidioidomycosis: mucosal ulcers and destructive pulmonary disease | Pilot-wheel or mariner's wheel budding yeast with multiple buds; itraconazole or amphotericin B |
| Sporothrix schenckii | Worldwide in soil and on plants, classically on rose thorns | Sporotrichosis: subcutaneous nodule tracking along lymphatics after a prick | Cigar-shaped yeast on culture; itraconazole |
| Talaromyces marneffei (formerly Penicillium marneffei) | Southeast Asia and southern China | Disseminated infection in advanced AIDS, with umbilicated skin lesions | A dimorphic fungus that is a useful differential in AIDS patients from the region; amphotericin B then itraconazole |
NotePneumocystis jirovecii is no longer classified as a fungus, but it is cemented into every mycological answer by habit. It is an obligate extracellular organism that cannot be cultured, its diagnosis rests on staining the foamy material from bronchoalveolar lavage or on the beta-D-glucan blood test, and its treatment is high-dose trimethoprim–sulfamethoxazole with adjunctive corticosteroids when the patient is hypoxaemic — the prototypal opportunistic pneumonia of the CD4-count-below-200 patient.
Antifungal pharmacology: attacking the eukaryotic differences
| Class | Target | Agents | Principal toxicity |
|---|---|---|---|
| Polyene | Ergosterol in the fungal membrane — the drug physically complexes it | Amphotericin B (including lipid formulations), nystatin | Nephrotoxicity, hypokalaemia, hypomagnesaemia, and infusion reactions; lipid formulations reduce renal toxicity |
| Azole | Fungal CYP51, blocking lanosterol demethylation and therefore ergosterol synthesis | Fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole | Hepatotoxicity, QT prolongation, CYP interactions, and in pregnancy a teratogenic risk |
| Echinocandin | Beta-1,3-glucan synthase, so the wall cannot be built | Caspofungin, micafungin, anidulafungin | Very well tolerated; no cross-resistance with azoles or polyenes; first-line for invasive candidiasis |
| Allylamine | Squalene epoxidase, blocking ergosterol synthesis earlier | Terbinafine | Gastrointestinal upset, taste disturbance, rare hepatotoxicity; the standard for onychomycosis |
| Nucleotide analogue | Cytosine deaminase converts to 5-fluorouracil, inhibiting nucleic acid synthesis | Flucytosine | Bone marrow suppression, so it is always used in combination |
| Topical agents | Various | Nystatin, clotrimazole, ciclopirox | Local irritation only |
Watch outAntifungal resistance is growing and comes with predictable mechanisms. Candida glabrata acquires ergosterol-pathway mutations and efflux pump over-expression that lower fluconazole susceptibility; Aspergillus develops CYP51 mutations conferring voriconazole resistance, particularly after agricultural azole exposure; and the echinocandins fail against Cryptococcus and against all Mucorales, which have little of the target they attack.
Common mistakes
Watch outCalling all hyphae the same. Aspergillus is septate and branches at about 45 degrees; Mucorales is aseptate, wide and branches at right angles. The two diseases differ in drug choice, in the need for surgery, and in outcome, and the distinction is made by looking at the hyphae in tissue, not by reading the culture plate.
Watch outDiagnosing oral thrush in someone with dentures and wiping it off with a spatula. Thrush is a creamy plaqued membrane that leaves an erythematous bleeding base; a denture ulcer does not scrape off, and leukoplakia cannot be scraped at all. If it does not come off, it is not thrush.
Watch outBelieving HIV is the only immunodeficiency that matters in mycology. Neutropenia, high-dose corticosteroids, transplant immunosuppression and the newer therapies targeting interleukin-17 and Janus kinases all create fungal susceptibility, and the newest mucormycosis outbreaks in diabetic ketoacidosis and after COVID-19 pneumonia have nothing to do with HIV.
Check your understanding
A neutropenic chemotherapy patient has a necrotising pneumonia, and a lung biopsy shows broad, aseptate, right-angle branching hyphae. What is the organism, the drug, and why is the culture likely to be negative?
Why is amphotericin B toxic to human kidneys when it was designed for a fungus?
A patient with AIDS and a CD4 count of 40 has headache, fever and neck stiffness. The CSF shows capsulated budding yeasts on India ink. Outline the treatment and the reason for its phases.
Multiple choice
Which statement about Aspergillus and Mucorales is correct?
A KOH scrape of a scaly interdigital foot lesion shows refractile branching septate hyphae. Which genera cause this disease, and how is the tinea named?
Which pairing of antifungal agent with its mechanism is correct?
Summary and next
Fungal disease divides into the dermatophyte infections of keratinised tissue, and the opportunists that require a defect in host defence. Candida, the polymorphic commensal, is identified by germ tube and by chlamydospores and is treated with an echinocandin or fluconazole depending on whether the disease is mucosal or invasive. Cryptococcus is diagnosed by the India ink halo and cryptococcal antigen, and treated with amphotericin B plus flucytosine. Aspergillus and Mucorales are separated by hyphal geometry — septate at an acute angle versus aseptate at right angles — and the difference decides the drug and the need for surgery. The therapeutic space is narrow because fungi are eukaryotes, and the polyenes, azoles, echinocandins and allylamines attack the ergosterol-rich membrane or the chitinous wall.
Next: protozoan parasites. You will meet Plasmodium, Entamoeba, Leishmania, Giardia, Toxoplasma and Trichomonas — their life cycles, their vectors, and the microscopic findings that identify them.